Copyright 2016 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
In the current issue of JAMA, the US Preventive Services Task Force (USPSTF) has published the results of its most recent evidence reviews and recommendations on screening for lipid disorders in children and adolescents.1-3 The recommendation statement is an I statement, meaning that the USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for lipid disorders in children and adolescents 20 years or younger. This is an update of the last statement, which had a similar recommendation and grade.4
Daniels SR. On the US Preventive Services Task Force Statement on Screening for Lipid Disorders in Children and Adolescents: One Step Forward and 2 Steps Sideways. JAMA Pediatr. 2016;170(10):932–934. doi:10.1001/jamapediatrics.2016.2315
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: